DTMXF logo

Datametrex AI Limited (DTMXF)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Datametrex AI Limited (DTMXF) ist im Technology-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 39/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
39/100 KI-Bewertung

Datametrex AI Limited (DTMXF) Technologieprofil & Wettbewerbsposition

CEODong Hyun Shim
Mitarbeiter21
HauptsitzToronto, CA
IPO-Jahr2017

Datametrex AI Limited provides AI-powered data analytics and health security solutions, operating primarily in Canada and South Korea. The company leverages machine learning for data collection, analysis, and presentation, serving industries through its AI and Technology, and Health Security segments. It faces competition in the rapidly evolving AI and health tech landscape.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Datametrex AI Limited presents a speculative investment opportunity within the AI and health security sectors. The company's negative profit margin of -114.8% indicates it is not currently profitable. Revenue growth and market expansion, particularly in the health security segment, are key value drivers. Successful adoption of its Medi-Call app and NexaSecurity platform could drive future growth. However, the company's small market capitalization and OTC listing introduce significant risk. The investment thesis hinges on Datametrex's ability to scale its AI solutions and achieve profitability in a competitive market. Investors should closely monitor financial performance and market traction.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
  • Negative P/E ratio of -0.74 reflects current unprofitability, requiring careful monitoring of future earnings.
  • Gross margin of -13.4% suggests challenges in cost management and pricing strategy.
  • Beta of 1.26 indicates higher volatility compared to the market, appealing to risk-tolerant investors.
  • Operations in both Canada and South Korea provide geographic diversification and exposure to different market dynamics.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Patented AI technology provides a competitive edge.
  • Diversified service offerings across AI, technology, and health security.
  • Presence in both Canada and South Korea offers geographic diversification.
  • Proprietary NexaSecurity platform provides specialized social media monitoring capabilities.

Schwaechen

  • Negative profit margin indicates financial instability.
  • Small market capitalization increases volatility and risk.
  • Reliance on COVID-19 related services may decline as the pandemic subsides.
  • Limited brand recognition compared to larger competitors.

Katalysatoren

  • Upcoming: Potential partnerships with healthcare providers to expand Medi-Call adoption.
  • Ongoing: Increasing demand for AI-driven data analytics solutions in various sectors.
  • Ongoing: Expansion of NexaSecurity platform to new industries and clients.

Risiken

  • Potential: Intense competition from larger AI and IT service providers.
  • Potential: Rapid technological advancements may render existing solutions obsolete.
  • Ongoing: Negative profit margin indicates financial instability.
  • Ongoing: OTC listing and small market capitalization increase volatility and risk.
  • Potential: Regulatory changes in the healthcare and data privacy sectors.

Wachstumschancen

  • Expansion of Medi-Call App: The Medi-Call health app represents a significant growth opportunity for Datametrex. As telemedicine gains wider acceptance, the company can leverage this platform to connect more patients with doctors, offering subscription-based e-health services. The global telemedicine market is projected to reach $431.82 billion by 2030, growing at a CAGR of 25.9% from 2023. Successful marketing and adoption of Medi-Call could drive recurring revenue and establish Datametrex as a key player in the digital health space.
  • NexaSecurity Platform Adoption: Datametrex's NexaSecurity platform offers social media discovery and monitoring capabilities. With increasing concerns about online security and misinformation, demand for social media monitoring tools is growing. The social media analytics market is expected to reach $16.55 billion by 2030, growing at a CAGR of 17.2%. By enhancing the platform's features and targeting specific industries, Datametrex can capitalize on this trend and generate revenue through subscriptions and customized solutions.
  • AI-Driven Data Analytics Services: Datametrex's core strength lies in its AI-driven data analytics capabilities. As businesses generate vast amounts of data, the need for AI-powered solutions to extract insights and improve decision-making is increasing. The global big data and analytics market is projected to reach $549.7 billion by 2028, growing at a CAGR of 13.2%. Datametrex can focus on specific sectors, such as healthcare and finance, to provide tailored data analytics services and secure long-term contracts.
  • Strategic Partnerships: Forming strategic partnerships with established companies in the technology and healthcare sectors can accelerate Datametrex's growth. Collaborating with larger firms can provide access to new markets, technologies, and customer bases. For example, partnering with a major hospital network could facilitate the adoption of Medi-Call and other health security services. These partnerships can enhance Datametrex's credibility and expand its reach.
  • Geographic Expansion: While Datametrex currently operates in Canada and South Korea, expanding into new geographic markets represents a significant growth opportunity. Targeting regions with high demand for AI solutions and telemedicine services can diversify revenue streams and reduce reliance on existing markets. Conducting market research and establishing local partnerships are crucial for successful geographic expansion. This could include entering the US or European markets.

Chancen

  • Expansion of telemedicine services through the Medi-Call app.
  • Growing demand for AI-driven data analytics solutions.
  • Strategic partnerships with established companies in the technology and healthcare sectors.
  • Geographic expansion into new markets with high demand for AI and telemedicine.

Risiken

  • Intense competition from larger and better-funded AI and IT service providers.
  • Rapid technological advancements may render existing solutions obsolete.
  • Regulatory changes in the healthcare and data privacy sectors.
  • Economic downturns may reduce demand for AI and technology services.

Wettbewerbsvorteile

  • Patented machine learning and artificial intelligence technology.
  • Diversified service portfolio across AI, technology, and health security.
  • Established presence in both Canada and South Korea.
  • Proprietary NexaSecurity social media monitoring platform.

Ueber DTMXF

Datametrex AI Limited, headquartered in Toronto, Canada, specializes in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. The company was founded to leverage AI for diverse applications, evolving into two primary segments: AI and Technology, and Health Security. The AI and Technology segment focuses on providing big data analytics and system integration services. The Health Security segment offers COVID-19 related services, concierge medical services, and telemedicine solutions. Datametrex offers a range of products including NexaSecurity, a social media monitoring platform, and Medi-Call, a health app connecting patients with doctors for e-health services. The company also sells COVID-19 test kits. Datametrex operates primarily in Canada and South Korea, aiming to expand its AI-driven solutions across various sectors. Its competitive positioning relies on patented AI technology and a diversified service portfolio, addressing both technological and health-related needs.

Was das Unternehmen tut

  • Collects and analyzes structured and unstructured data.
  • Develops and applies machine learning and artificial intelligence solutions.
  • Offers health security services, including COVID-19 related services.
  • Provides concierge medical services and telemedicine solutions.
  • Sells COVID-19 test kits.
  • Offers NexaSecurity, a social-media discovery and monitoring platform.
  • Provides Medi-Call health app, connecting patients with doctors.

Geschaeftsmodell

  • Provides AI and Technology solutions, generating revenue through contracts and service fees.
  • Offers Health Security services, earning revenue through service fees and product sales.
  • Sells subscriptions to the Medi-Call health app.
  • Generates revenue from the NexaSecurity platform through subscriptions and customized solutions.

Branchenkontext

Datametrex AI Limited operates within the rapidly evolving AI and information technology services industry. The market is characterized by increasing demand for data analytics, machine learning solutions, and telemedicine services. Competition includes established IT service providers and specialized AI firms. Datametrex's focus on both AI and health security positions it uniquely, but it faces challenges in scaling and competing with larger, better-funded players. The industry is driven by technological advancements, regulatory changes, and the increasing adoption of digital health solutions.

Wichtige Kunden

  • Businesses seeking AI-driven data analytics solutions.
  • Healthcare providers and patients utilizing telemedicine services.
  • Organizations requiring social media monitoring and security solutions.
  • Government agencies needing data analysis and security services.
KI-Zuversicht: 69% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Datametrex AI Limited (DTMXF) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer DTMXF.

Kursziele

Wall-Street-Kurszielanalyse fuer DTMXF.

MoonshotScore

39/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von DTMXF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Dong Hyun Shim

CEO

Dong Hyun Shim serves as the CEO of Datametrex AI Limited, leading a team of 21 employees. Information regarding his detailed career history, educational background, and previous roles is not available. His leadership is focused on guiding the company's strategic direction in the AI, technology, and health security sectors. He is responsible for overseeing the development and implementation of Datametrex's AI-driven solutions and expanding its market presence in Canada and South Korea.

Erfolgsbilanz: Due to limited information, specific achievements, strategic decisions, and company milestones under Dong Hyun Shim's leadership cannot be detailed. His tenure and impact on Datametrex's performance require further assessment based on available financial reports and company announcements.

DTMXF OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Datametrex AI Limited may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be current in their reporting obligations. Investing in OTC Other stocks carries significant risks due to the potential for lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier is also known as the Pink Open Market.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for DTMXF is likely limited due to its OTC listing and small market capitalization. This can result in wider bid-ask spreads and greater difficulty in buying or selling shares without significantly impacting the price. Low trading volumes may also increase price volatility and make it challenging to execute large orders. Investors should exercise caution and be aware of the potential for illiquidity.
OTC-Risikofaktoren:
  • Limited financial disclosure increases the risk of investing in DTMXF.
  • Low liquidity can make it difficult to buy or sell shares at desired prices.
  • Higher price volatility due to the OTC listing and small market capitalization.
  • Potential for fraud or manipulation due to less regulatory oversight.
  • OTC Other tier status indicates the company may not meet minimum financial standards.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial reporting status and access available financial statements.
  • Assess the trading volume and bid-ask spread to understand liquidity risks.
  • Research the company's management team and their track record.
  • Review the company's filings and disclosures on the OTC Markets website.
  • Consult with a financial advisor to assess the risks and suitability of investing in DTMXF.
  • Understand the company's business model and competitive landscape.
  • Confirm the legitimacy of the company's operations and assets.
Legitimitaetssignale:
  • Operations in Canada and South Korea suggest established business activities.
  • Patented AI technology indicates innovation and intellectual property.
  • Presence of a CEO and management team suggests organizational structure.
  • Provision of health security services indicates engagement with regulated industries.

Was Anleger ueber Datametrex AI Limited (DTMXF) wissen wollen

What are the key factors to evaluate for DTMXF?

Datametrex AI Limited (DTMXF) currently holds an AI score of 39/100, indicating low score. Key strength: Patented AI technology provides a competitive edge.. Primary risk to monitor: Potential: Intense competition from larger AI and IT service providers.. This is not financial advice.

How frequently does DTMXF data refresh on this page?

DTMXF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven DTMXF's recent stock price performance?

Recent price movement in Datametrex AI Limited (DTMXF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Patented AI technology provides a competitive edge.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider DTMXF overvalued or undervalued right now?

Determining whether Datametrex AI Limited (DTMXF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying DTMXF?

Before investing in Datametrex AI Limited (DTMXF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding DTMXF to a portfolio?

Potential reasons to consider Datametrex AI Limited (DTMXF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Patented AI technology provides a competitive edge.. Additionally: Diversified service offerings across AI, technology, and health security.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of DTMXF?

Yes, most major brokerages offer fractional shares of Datametrex AI Limited (DTMXF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track DTMXF's earnings and financial reports?

Datametrex AI Limited (DTMXF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for DTMXF earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited information available on CEO track record.
  • Lack of analyst coverage impacts investment thesis validation.
  • OTC market carries inherent risks due to limited regulation and disclosure.
Datenquellen

Popular Stocks